Jump to content

Previous NASA Awards for In Space Production Applications


Recommended Posts

  • Publishers
Posted
Astronaut Kayla Barron works on a space agriculture study
NASA astronaut Kayla Barron works inside the Life Science Glovebox conducting botany research.
NASA

As of spring 2023, NASA has invested greater than $60M in more than twenty In Space Production Applications (InSPA) awards to U.S. entities seeking to demonstrate the production of advanced materials and products on the International Space Station.  These InSPA awards help the selected companies raise the technological readiness level of their products and move them to market, propelling U.S. industry toward the development of a sustainable, scalable, and profitable non-NASA demand for services and products manufactured in the microgravity environment of low-Earth orbit for use on Earth.

Advanced Materials

Flawless Photonics – Fabrication of Flawless Glass

Contact: Dr. Michael Vestel
Flawless Photonics of Los Altos Hills, California, in partnership with the University of Adelaide, Axiom Space, and Visioneering Space has been selected for their proposal to develop specialized glass manufacturing hardware to process Heavy-Metal Fluoride Glasses (HMFG) in microgravity. HMFG glasses are used in the terrestrial manufacturing of exotic optical fibers and other optics applications. Without convective forces present in 1g, HMFG made in microgravity are expected to achieve the ideal amorphous microstructure during synthesis, eliminating light scattering defects that limit lasing power and transmission over long fiber lengths.

Apsidal – Intelligent Glass Optics

Contact: Dr. Amrit De
Apsidal LLC. of Los Angeles, California, is developing the IGO module to process various types of complex glasses in space from which optical fibers, fiber lasers, magnetic fibers, super-continuum sources, capillary optics and adiabatic tapers can be drawn. One of the key innovations is a custom Laser Doppler Sensor for real-time in-situ analysis and feedback control of the manufacturing process. Additionally, this technology is Artificial Intelligence (AI) assisted to be adaptive and to optimize production in a low Earth orbit (LEO) environment. The microgravity environment of space is needed as gravity-induced material convection and sedimentation in complex glasses on Earth subsequently leads to unwanted crystallization, thus creating defects which reduce performance. Market areas for products from this module include specialty fibers for low-loss and high bandwidth communications, high-power fiber-amplifiers, IR counter measures, supercontinuum sources, medical applications, remote sensing, X-ray optics, and laser processing.

Fiber Optic Manufacturing in Space – Space Fibers

Contact: Dr. Dmitry Starodubov
FOMS Inc of San Diego, California, has developed a facility-class instrument for fiber fabrication in the microgravity environment to improve the quality of specialty optical fibers with the promise of up to 100x reduction in insertion loss due to the suppression of crystallization and phase separation. Two previous iterations of the facility have flown to the space station, with the third generation scheduled to launch on the 25th SpaceX cargo resupply services mission in May 2022.

Mercury Systems Torrance – Fiber Optic Production

Contact: Eric Rucker
Mercury Systems of Torrance, California, has developed a facility-class instrument for fiber fabrication in the microgravity environment to improve the quality of specialty optical fibers with the promise of up to two orders of magnitude reduction in insertion loss compared to traditional SiO2 fibers due to the suppression of crystallization and sedimentation. The first generation of the facility has flown to the space station producing over 90m of ZBLAN optical fiber from a fluorinated exotic glass preform composed of Zirconium, Barium, Lanthanum, Aluminum, and Sodium (ZrF4-BaF2-LaF3-AlF3-NaF). The second-generation FOP-2 launches on SpaceX CRS-25 in May 2022 using a nitrogen purge previously demonstrated in reduced gravity on a parabolic flight.

Redwire/Made In Space – Turbine Ceramic Manufacturing Module

Contact: Justin Kugler
Made In Space of Jacksonville, Florida, a Redwire company, is developing the TCMM to provide proof-of-principal for single-piece ceramic turbine blisk (blade + disk) manufacturing in microgravity for terrestrial use. Launched in October 2020 on Northrop Grumman’s CRS-14 mission, TCMM successfully demonstrated ceramic additive manufacturing in space for the first time in history. TCMM was also the first demonstration of stereolithography ceramic fabrication in space. The project focuses on advanced materials engineering ultimately leading to reductions in part mass, residual stress, and fatigue. Strength improvements of even 1-2 percent, as a result of being manufactured in microgravity, can yield years to decades of superior service life. Market applications include high performance turbines, nuclear plants, or internal combustion engines.

Redwire/Made In Space – Turbine Superalloy Casting Module

Made In Space of Jacksonville, Florida, a Redwire company, is developing the TSCM to provide proof of principle for polycrystal superalloy part manufacturing in microgravity for terrestrial use. Superalloys thermally processed in microgravity could have improved microstructure and mechanical properties over superalloys processed on Earth. This work expands utilization of the ISS National Lab into new commercial product areas not previously investigated.

Delivered to space station on SpaceX CRS-24 in December 2021, TSCM investigates potential improvements in superalloy microstructure by heat treating in microgravity. Market applications include turbine engines in industries such as aerospace and power generation.

Redwire/Techshot – Pharmaceutical In-space Laboratory 

Contact: Rachel Ormsby
Redwire Corporation Inc. of Greenville, Indiana, has been selected for its proposal to produce small, uniform crystals as stable seed batches for pharmaceutical and institutional research customers seeking improvements/refinements in product purification, formulation and/or delivery using crystalline formulations. Their Pharmaceutical In-space Laboratory Bio-crystal Optimization Xperiment (PIL-BOX) Dynamic Microscopy Cassette (DMC) will be capable of testing multiple crystallization conditions and providing samples to be returned to Earth for analysis. When grown in microgravity, crystals are produced more uniformly and have very low size coefficients of variation thereby allowing a more stable crystal growth, high concentration, and low viscosity parenteral formulation. The proposed innovation will provide manufacturing services to companies, institutions, and agencies pursuing uniform crystallization research.

United Semiconductors – Semimetal-Semiconductor Composite Bulk Crystals

Contact: Dr. Dutta
United Semiconductors of Los Alamitos, California, has been selected for their proposal to produce semimetal-semiconductor composite bulk crystals commonly used in electromagnetic sensors for solving challenges in the energy, high performance computing and national security sectors. Together with teammates Axiom Space of Houston and Redwire of Greenville, Indiana, United Semiconductors intends to validate the scaling and efficacy of producing larger semimetal-semiconductor composite crystals under microgravity conditions with perfectly aligned and continuous semimetal wires embedded across the semiconductor matrix. If successful at eliminating defects found in those manufactured with terrestrial materials, United Semiconductors will have developed a processing technology for creating device-ready wafers from space-grown crystals.

image of crystal growth in a semiconductor composite wafer
Optical Micrograph depicting the expected morphology of Semimetal-Semiconductor Composite (SSC) wafers to be extracted from space grown bulk crystals. The continuous semimetal needles embedded in semiconductor matrix will provide high yield of high-performance electromagnetic sensors. Currently this desirable morphology is seen only in a small fraction of the terrestrial grown bulk crystals. Space grown bulk crystals is anticipated to provide a significant volume of the desirable morphology.
United Semiconductors LLC
image of crystal growth in a semiconductor composite wafer
Optical Micrograph depicting the morphology of Semimetal-Semiconductor Composite (SSC) wafers extracted from terrestrial grown bulk crystals. Discontinuous semimetal needles embedded in semiconductor matrix leads to poor yield of high-performance electromagnetic sensors.
United Semiconductors LLC

Redwire/Made In Space – Industrial Crystallization Facility

Contact: Justin Kugler
Made In Space of Jacksonville, Florida, a Redwire company, is developing the ICF to provide proof-of-principle for diffusion-based crystallization methods to produce high-quality optical crystals in microgravity relevant for terrestrial use. ICF launched to the International Space Station on Northrop Grumman’s CRS-15 on February 20, 2021. It was the first facility to grow inorganic potassium dihydrogen phosphate (KDP) crystals aboard space station, offering important insight into microgravity-enabled growth processes for industrial crystals, which could yield opportunities for commercial production on-orbit. Market applications include ultra-fast optical switches, optical waveguides, optical circuit lithography, high-efficiency ultraviolet light production, and terahertz wave sensors. 

Tissue Engineering & Biomanufacturing

LambdaVision/Space Tango –Retinal Implant

Contact: Alain Berinstain
Space Tango of Lexington, Kentucky, and its partner, LambdaVision of Farmington, Connecticut, are developing a system to manufacture protein-based retinal implants, or artificial retinas, in microgravity. The market for this work is the millions of patients suffering from retinal degenerative diseases, including retinitis pigmentosa (RP) and age-related macular degeneration (AMD), a leading cause of blindness for adults over 55 years old. This effort builds on a validation flight completed in late 2018 that demonstrated the proof of concept for generating multilayered protein-based thin films in space using a miniaturized layer-by-layer manufacturing device. This project will further mature the manufacturing system, producing protein-based artificial retinas in space that would be returned to Earth for preclinical evaluation of the technology. This work will establish the necessary regulatory requirements for producing biomedical products in space station, including current Good Manufacturing Practices (cGMP). The microgravity environment of space hinders convection and sedimentation in the manufacturing process, enabling more uniform layers, improved stability and higher quality thin films than can be produced on Earth. The team successfully produced 200 layers of protein on their most recent flight on SpaceX Crew-4.

diagram of a human eye and an artificial retina
Using greater uniformity and better film deposition in microgravity to produce 100 layers of precisely aligned, precisely structured layers of bacterial rhodopsin crystals (vision protein) sandwiched between 100 layers of precisely deposited composite material with sufficient quality to enable an implantable artificial retina to FDA approval.
LambdaVision

Redwire/Made In Space – Manufacturing of Semiconductors and Thin-film Integrated Coatings (MSTIC)

Contact: Justin Kugler
Made In Space of Jacksonville, Florida, a Redwire company, is developing the MSTIC facility as an autonomous, high throughput manufacturing capability for production of high quality, lower cost semiconductor chips at a rapid rate. Terrestrial semiconductor chip production suffers from the impacts of convection and sedimentation in the manufacturing process. Fabricating in microgravity is expected to reduce the number of gravity-induced defects, resulting in more usable chips per wafer. Market applications include semiconductor supply chains for telecommunications and energy industries.

Auxilium Biotechnologies/Space Tango – Drug Delivery Medical Devices

Contact: Dr. Jacob Koffler
Auxilium Biotechnologies with Space Tango has been selected for its proposal to develop a second-generation drug-delivery medical device to more effectively treat people who have sustained traumatic peripheral nerve injury. Auxilium’s Gen 1.0 NeuroSpan Bridge is a biomimetic nerve regeneration device that guides and accelerates nerve regeneration, eliminating the need for a patient to sacrifice a nerve in the leg to repair a nerve in the arm or face. Auxilium will use its expertise in fast, high-resolution 3D-printing to adapt its proprietary platform to a Gen 2.0 3D-print device in microgravity by adding novel drug delivery nanoparticles with the potential to substantially accelerate regeneration and improve functional outcomes for people on Earth.

Lawrence Livermore National Lab/Space Tango – VAM Organ Production

Contact: Dr. Maxim Shusteff
Lawrence Livermore National Laboratory, located in Livermore, California, in partnership with Space Tango, has been selected for their proposal to adapt their terrestrial volumetric 3D bioprinting device for use in microgravity to demonstrate production of artificial cartilage tissue in space. The Volumetric Additive Manufacturing (VAM) technology is a revolutionary, ultra-rapid 3D printing method that solidifies a complete 3D structure from a photosensitive liquid resin in minutes. Because of the absence of settling and gravity-driven buoyancy and convective flows in the prepolymer, the cartilage tissues manufactured and matured in microgravity are expected to have superior structural, organizational, and mechanical properties suitable for use in long-term tissue repair and replacement.

University of Connecticut, STORRS/Axiom – Biomimetic Fabrication of Multifunctional DNA-inspired Nanomaterials

Contact: Dr. Yupeng Chen
The University of Connecticut, out of Storrs, Connecticut, in partnership with Eascra Biotech of Boston, Massachusetts and Axiom Space of Houston has been selected for their proposed biomimetic fabrication of multifunctional nanomaterials, a cutting-edge breakthrough in biomedicine that can benefit from microgravity in space to accomplish controlled self-assembly of DNA-inspired Janus base nanomaterials (JBNs). These JBNs will be used as effective, safe and stable delivery vehicles for RNA therapeutics and vaccines, as well as first-in-kind injectable scaffolds for regenerative medicine. By leveraging the benefits of microgravity, the UConn/Eascra team expects to mature in-space production of different types of JBNs with more orderly structures and higher homogeneity over what is possible using terrestrial materials, improving efficacy for mRNA therapeutics and structural integrity for cartilage tissue repair.

diagram of mRNA therapeutics manufacturing process
In-space manufacturing of DNA-inspired Janus base nanomaterials for delivery of mRNA therapeutics and vaccines, and tissue repair and regeneration.
Dr. Yupeng Chenu

BioServe Space Technologies with University of Colorado – Expansion of Hematopoietic Stem Cells

Contact: Dr. Louis Stodieck
BioServe Space Technologies and The University of Colorado of Boulder, Colorado, in collaboration with the Mayo Clinic, ClinImmune Cell and Gene Therapy (University of Colorado Anschutz Medical Campus), RheumaGen, and with support from Sierra Space has been selected for their proposal to develop a specialized bioreactor that will produce large populations of Hematopoietic Stem Cells (HSCs) in microgravity to treat serious medical conditions including blood cancers (leukemias, lymphomas, multiple myeloma), blood disorders, severe immune diseases, and certain autoimmune diseases, such as rheumatoid arthritis. Expansion of HSCs in microgravity is expected to result in greater stem cell expansion with less cell differentiation than is seen in 1g. If successful, the technology may enable safe and effective cell therapy transplantation, especially in children and younger adults, where long-term bone marrow cell repopulation is critical to the patient’s lifetime health.

image of an astronaut working with an experiment
Astronaut Thomas Pesquet working in the Space Automated Bioproduct Laboratory (SABL). This image shows two SABL units, one open and one closed. SABL will be used for growing and expanding BioServe’s stem cells on board the ISS.
NASA

Cedars Sinai Regenerative Medicine Institute/Axiom – Stem Cell Therapy

Contact: Dr. Clive Svendsen
Cedars-Sinai Regenerative Medicine Institute, located in Los Angeles in partnership with Axiom Space of Houston has been selected for proposing to use cutting-edge methods related to the production and differentiation of induced pluripotent stem cells (iPSCs) on the International Space Station. Cedars-Sinai will explore in-space production of stem cells into heart, brain, and blood tissues in support of regenerative medicine uses on Earth. While stem cells and stem cell-derived tissues hold great promise for use in research and as clinical-grade therapeutic agents, safe and efficient expansion of stem cells and their derivatives continues to be a major challenge on Earth. Generating, expanding, and differentiating cells at scale in the microgravity environment of space with sufficient yields of a constant therapeutic cell product that meets FDA biologics requirements may be the answer to overcome those challenges.

Redwire/Techshot – BioFabrication Facility

Contact: Rich Boling
Techshot of Greenville, Indiana, a Redwire company, is developing the BFF as a space-based 3D biomanufacturing platform capable of printing with live human cells (autologous or allogenic). The facility contains an XYZ gantry with multiple print heads and a bioreactor cassette in the X-Y plane. Without the addition of scaffolding or chemical bio-ink thickening agents, attempts to 3D print with cells on Earth only results in creating a puddle. With scaffolding and thickening agents, organ-like shapes can be printed on Earth, but they cannot function as such. BFF prints in space with low viscosity bio-inks that only contain cells and nutrients, which enable cells to remain healthy and mobile – a necessity for creating solid thick tissue. Following a weeks-long in-space conditioning phase inside a special Redwire bioreactor, the tissue constructs are strong enough to resist gravity and remain viable following their return to Earth. In 2020, Redwire manufactured test prints of a partial human meniscus aboard the International Space Station for the company’s DoD customer, the 4-Dimensional Bioprinting, Biofabrication, and Biomanufacturing, or 4D Bio3 program, based at Uniformed Services University of the Health Sciences. The program is a collaboration between the university and The Geneva Foundation, a non-profit organization that advances military medical research. A second round of printing in space for 4D Bio3 is scheduled for late 2022 after delivery of a 2nd generation printer on SpaceX CRS-26.  Redwire is planning additional bioprinting operations with the BFF, such as the Fabrication in Austere Military Environments (FAME) bioprinting program. Market applications include human tissue and organ repair or replacement.

Redwire/Techshot – Cell Reprogramming Facility

Contact: Rich Boling
Techshot of Greenville, Indiana, a Redwire company, is developing the CRF to manufacture induced pluripotent stem cells (iPSCs) in orbit using adult cells, then enabling the cells to develop into many other types of cells, that can be used inside the BFF bioprinter and on Earth for regenerative medicine, especially cell therapies. The first element of the Cell Factory system – the CRF – is in development now. Market applications include cell therapies for restorative health and autologous cell sourcing for bioprinting and vascular applications.

Cedars Sinai/Space Tango – Stem Cell Production

Contact: Alain Berinstain
Space Tango of Lexington, Kentucky, and its partner Cedars-Sinai of Los Angeles, California, are developing pilot-scale systems for the production in space of large batches of stem cells to be used in personalized medical treatment for a variety of diseases. The development of induced pluripotent stem cells (iPSC) for commercial personalized medicine applications is done in space because the work to date on the space station demonstrates stem cells retain their “stemness” for longer durations in microgravity, allowing a delay of differentiation that has the potential to enable larger batches of cells to be produced. The pilot-scale systems, built for the space station to serve as a basis for future commercial manufacturing systems, will incorporate regulatory strategies to support FDA clinical trial production of personalized medicine stem cell therapies on the space station. Including current Good Manufacturing Practices (cGMP) conditions, required for the production of stem cell therapies for human use in patients.

Sanford/Space Tango – Integrated Space Stem Cell Orbiting Lab

Contact: Alain Berinstain
Space Tango of Lexington, Kentucky, and its partners at UC San Diego/Sanford Consortium in La Jolla, California, are working to establish a new on-orbit biomedical sector for stem cell advancement, with a fully operational self-sustaining orbital laboratory anticipated by 2025. The team is working to refine current hardware capabilities and process flows, extending the capabilities of ground-based laboratories with regular access to the space station via secured flight opportunities. Stem cells differentiate into tissue specific progenitors that can be used in microgravity to better understand aging and immune dysfunction, providing an opportunity to accelerate advances in regenerative medicine and the development of potential new therapeutic approaches. The target market for this orbital laboratory is a new approach to stem cell translational medicine.

Wake Forest Institute of Regenerative Medicine/Axiom – Engineered Liver Tissue

Contact: Dr. Anthony Atala

Wake Forest Institute for Regenerative Medicine (WFIRM), located in Winston-Salem, North Carolina, has partnered with Axiom Space and BioServe Space Technologies to pursue a groundbreaking initiative. Their proposal takes advantage of the microgravity environment to develop and validate a platform that supports a ‘building block’ strategy for in-space manufacturing of vascularized and perfused liver tissue as a bridge to transplantation. This is a continuation of the NASA Centennial Vascular Tissue Challenge, where WFIRM teams won first and second place for creating metabolically active thick liver tissue that retained function for thirty days. The overarching goal is to enhance the formation of a microcapillary system within a perfusable 3D bioprinted vascularized engineered liver tissue constructs for biomanufacturing clinical-scale liver tissue constructs that allow integration into the recipient’s peripheral circulation for the treatment of liver disease. Once validated, this platform technology can produce multiple tissue construct types, including kidney and pancreas, among others. In Phase 1a, the team plans to evaluate various 3D bioprinted designs for vascularized tissue constructs to be evaluated in microgravity to identify the optimal parameters to produce liver tissue that is suitable in size to serve as a bridge to regeneration or transplantation. Phases 2 and 3 will involve biomanufacturing liver tissue constructs of the optimal design for human clinical trials and process scale-up for future commercialization.

View the full article

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Similar Topics

    • By NASA
      The four crew members of NASA’s SpaceX Crew-9 mission, including NASA astronauts Nick Hague, Suni Williams, and Butch Wilmore, along with Roscosmos cosmonaut Aleksandr Gorbunov, pose for a photo aboard the International Space StationNASA Media are invited to hear from NASA’s SpaceX Crew-9 astronauts during a news conference beginning at 11:55 a.m. EST, Tuesday, March 4, from the International Space Station.
      NASA astronauts Nick Hague, Suni Williams, and Butch Wilmore will discuss their return to Earth on NASA+. Learn how to watch NASA content through a variety of platforms, including social media.
      Media interested in participating must contact the newsroom at NASA’s Johnson Space Center in Houston no later than 5 p.m. Monday, March 3, at 281-483-5111 or jsccommu@mail.nasa.gov. To ask questions, media must dial into the news conference no later than 15 minutes prior to the start of the call. A copy of NASA’s media accreditation policy is online. Questions also may be submitted on social media using #AskNASA.
      Crew-9 contributed to hundreds of scientific experiments, including swabbing the station’s exterior for microbes, printing 3D medical devices, and studying how moisture, orbital altitude, and ultraviolet light affect plant growth.
      The crew will depart the space station after the arrival of Crew-10 and a short handover period. Ahead of Crew-9’s return, mission teams will review weather conditions at the splashdown sites off the coast of Florida prior to departure from station.
      The mission is part of NASA’s Commercial Crew Program, which provides reliable access to space, maximizing the use of the station for research and development and supporting future missions beyond low Earth orbit by partnering with private companies to transport astronauts to and from the space station. 
      Follow updates on the Crew-9 mission at:
      https://www.nasa.gov/station
      -end-
      Joshua Finch / Jimi Russell
      Headquarters, Washington
      202-358-1100
      joshua.a.finch@nasa.gov / james.j.russell@nasa.gov
      Courtney Beasley
      Johnson Space Center, Houston
      281-483-5111
      courtney.m.beasley@nasa.gov
      Share
      Details
      Last Updated Feb 26, 2025 LocationNASA Headquarters Related Terms
      Humans in Space Astronauts Barry E. Wilmore International Space Station (ISS) Sunita L. Williams
      View the full article
    • By NASA
      Intuitive Machines-2: Delivering Science and Tech to the Moon (NASA Mission Trailer)
    • By NASA
      Intuitive Machines-2 Launch to the Moon (Official NASA Broadcast)
    • By NASA
      6 Min Read NASA Stennis Flashback: Learning About Rocket Engine Smoke for Safe Space Travel
      An image shows engineers at an early version of the test stand at the Diagnostic Testbed Facility. From 1988 to the mid-1990s, NASA Stennis engineers operated the facility to conduct rocket engine plume exhaust diagnostics and learn more about the space shuttle main engine combustion process. Credits: NASA/Stennis NASA’s Stennis Space Center near Bay St. Louis, Mississippi, is widely known as the nation’s largest rocket propulsion test site. More than 35 years ago, it also served as a hands-on classroom for NASA engineers seeking to improve the efficiency of space shuttle main engines.
      From 1988 to the mid-1990’s, NASA Stennis engineers operated a Diagnostic Test Facility to conduct rocket engine plume exhaust diagnostics and learn more about the space shuttle main engine combustion process. The effort also laid the groundwork for the frontline research-and-development testing conducted at the center today.
      “The Diagnostic Test Facility work is just another example of the can-do, will-do attitude of the NASA Stennis team and of its willingness to support the nation’s space exploration program in all ways needed and possible,” said Joe Schuyler, director of the NASA Stennis Engineering and Test Directorate.
      The Diagnostic Test Facility work is just another example of the can-do, will-do attitude of the NASA Stennis team…
      joe schuyler
      NASA Stennis Engineering and Test Directorate Director
      Tests conducted at the Diagnostic Testbed Facility played a critical safety role for engine operations and also provided a real-time opportunity for NASA Stennis engineers to learn about exhaust diagnostics. NASA/Stennis An image shows the Diagnostic Testbed Facility test stand data acquisition trailer. NASA/Stennis The Need
      Envision a rocket or space vehicle launching into the sky. A trail of bright exhaust, known as the engine plume, follows. As metals wear down in the engines from the intense heat of the combustion process, the flame glows with colors, some visible, such as orange or yellow, and others undetectable by the human eye.
      The colors tell a story – about the health and operation of the engine and its components. For space shuttle main engines, which flew on multiple missions, engineers needed to understand that story, much as a doctor needs to understand the condition of a human body during checkup, to ensure future engine operation.
      Where better place to study such details than the nation’s premier propulsion test site? Paging NASA Stennis.
      An image shows the rocket motor and thruster at the Diagnostic Testbed Facility. NASA/Stennis An image shows the Diagnostic Testbed Facility blended team of NASA personnel and contractors. Kneeling, left to right, is Brantly Adams (NASA), Felix Bircher (Sverdrup Technology), Dennis Butts (Sverdrup Technology), and Nikki Raines (Sverdrup Technology). Standing, left to right, NASA astronaut John Young, Greg Sakala (Sverdrup Technology), Barney Nokes (Sverdrup Technology), John Laboda (Sverdrup Technology), Glenn Varner (NASA), Stan Gill (NASA), Bud Nail (NASA), Don Sundeen (Sverdrup Technology), NASA astronaut John Blaha.NASA/Stennis The Facility
      NASA Stennis has long enabled and supported innovative and collaborative work to benefit both the agency and the commercial space industry. When NASA came calling in the late 1980s, site engineers went to work on a plan to study space shuttle main engine rocket exhaust.
      The concept for an enabling structure about the size of a home garage was born in October 1987. Five months later, construction began on a Diagnostic Testbed Facility to provide quality research capabilities for studying rocket engine exhaust and learning more about the metals burned off during hot fire.
      The completed facility featured a 1,300-square-foot control and data analysis center, as well as a rooftop observation deck. Small-scale infrastructure was located nearby for testing a 1,000-pound-thrust rocket engine that simulated the larger space shuttle main engine. The 1K engine measured about 2 feet in length and six inches in diameter. Using a small-scale engine allowed for greater flexibility and involved less cost than testing the much-larger space shuttle engine.
      An image shows Sverdrup Technology’s Robert Norfleet as he preps the dopant injection system for testing at the Diagnostic Testbed Facility. The goal of the facility was to inject known metals and materials in a chemical form and then look at what emissions were given off. During one test, generally a six or 12 second test, operators would inject three known dopants, or substances, and then run distilled water between each test to clean out the system.NASA/Stennis An image shows engineers Stan Gill, Robert Norfleet, and Elizabeth Valenti in the Diagnostic Testbed Facility test control center. NASA/Stennis The Process
      Engineers could quickly conduct multiple short-duration hot fires using the smaller engine. A six-second test provided ample time to collect data from engine exhaust that reached as high as 3,900 degrees Fahrenheit.
      Chemical solutions simulating engine materials were injected into the engine combustion chamber for each hot fire. The exhaust plume then was analyzed using a remote camera, spectrometer, and microcomputers to determine what colors certain metals and elements emit when burning.
      Each material produced a unique profile. By matching the profiles to the exhaust of space shuttle main engine tests conducted at NASA Stennis, determinations could be made about which engine components were undergoing wear and what maintenance was needed.
      We learned about purging, ignition, handling propellants, high-pressure gases, and all the components you had to have to make it work…It was a very good learning experience.
      Glenn Varner
      NASA Stennis Engineer
      The Benefits
      The Diagnostic Testbed Facility played a critical safety role for engine operations and also provided a real-time opportunity for NASA Stennis engineers to learn about exhaust diagnostics.
      Multiple tests were conducted. The average turnaround time between hot fires was 18 to 20 minutes with the best turnaround from one test to another taking just 12 minutes. By January 1991, the facility had recorded a total of 588 firings for a cumulative 3,452 seconds.
      As testing progressed, the facility team evolved into a collection of experts in plume diagnostics. Longtime NASA Stennis engineer Glenn Varner serves as the mechanical operations engineer at the Thad Cochran Test Stand, where he contributed to the successful testing of the first SLS (Space Launch System) core stage onsite.
      However, much of Varner’s hands-on experience came at the Diagnostic Test Facility. “We learned about purging, ignition, handling propellants, high-pressure gases, and all the components you had to have to make it work,” he said. “It was a very good learning experience.”
      An image shows the Diagnostic Testbed Facility team working in the test control center. Seated, left to right, is Steve Nunez, Glenn Varner, Joey Kirkpatrick. Standing, back row left to right, is Scott Dracon and Fritz Policelli. Vince Pachel is pictured standing wearing the headset. NASA/Stennis The physical remnants of the Diagnostic Testbed Facility are barely recognizable now, but that spirit and approach embodied by that effort and its teams continues in force at the center.
      joe schuyler
      NASA Stennis Engineering and Test Directorate Director
      The Impact
      The Diagnostic Testbed Facility impacted more than just those engineers involved in the testing. Following the initial research effort, the facility underwent modifications in January 1993. Two months later, facility operators completed a successful series of tests on a small-scale liquid hydrogen turbopump for a California-based aerospace company.
      The project marked an early collaboration between the center and a commercial company and helped pave the way for the continued success of the NASA Stennis E Test Complex. Building on Diagnostic Testbed Facility knowledge and equipment, the NASA Stennis complex now supports multiple commercial aerospace projects with its versatile infrastructure and team of propulsion test experts.
      “The physical remnants of the Diagnostic Testbed Facility are barely recognizable now,” Schuyler said. “But that spirit and approach embodied by that effort and its teams continues in force at the center.”
      Additional Information
      NASA Stennis has leveraged hardware and expertise from the Diagnostic Testbed Facility to provide benefit to NASA and industry for two decades and counting.
      The facility’s thruster, run tanks, valves, regulators and instrumentation were used in developing the versatile four-stand E Test Complex at NASA Stennis that includes 12 active test cell positions capable of various component, engine, and stage test activities.
      “The Diagnostic Testbed Facility was the precursor to that,” said NASA engineer Glenn Varner. “Everything but the structure still in the grass moved to the E-1 Test Stand, Cell 3. Plume diagnostics was part of the first testing there.”
      When plume diagnostic testing concluded at E-1, equipment moved to the E-3 Test Stand, where the same rocket engine used for the Diagnostic Testbed Facility has since performed many test projects.
      The Diagnostic Testbed Facility thruster also has been used for various projects at E-3, most recently in a project for the exploration upper stage being built for use on future Artemis missions. 
      In addition to hardware, engineers who worked at the Diagnostic Testbed Facility also moved on to support E Test Complex projects. There, they helped new NASA engineers learn how to handle gaseous hydrogen and liquid hydrogen propellants. Engineers learned about purging, ignition, and handling propellants and all the components needed for a successful test.
      “From an engineering perspective, the more knowledge you have of the processes and procedures to make propulsion work, the better off you are,” Varner said. “It applied then and still applies today. The Diagnostic Testbed Facility contributed to the future development of NASA Stennis infrastructure and expertise.”
      Share
      Details
      Last Updated Feb 25, 2025 EditorNASA Stennis CommunicationsContactC. Lacy Thompsoncalvin.l.thompson@nasa.gov / (228) 688-3333LocationStennis Space Center Related Terms
      Stennis Space Center Explore More
      4 min read NASA Stennis Flashback: Shuttle Team Achieves Unprecedented Milestone
      Article 7 months ago 4 min read Stennis Flashback: NASA Test Series Leads to Bold Space Shuttle Flight
      It may have been small, but the white puff of smoke exiting the B-2 Test…
      Article 2 years ago Keep Exploring Discover More Topics From NASA Stennis
      NASA’s Stennis Space Center History
      NASA Stennis Images
      NASA Stennis Fact Sheets
      NASA Stennis Front Door
      View the full article
    • By NASA
      Acting Director of NASA’s Johnson Space Center, Steve Koerner. Credit: NASA/Norah Moran NASA has selected Stephen Koerner as acting director of Johnson Space Center. Koerner previously served as Johnson’s deputy director.
      “It is an honor to accept my new role as acting director for Johnson,” Koerner said. “Our employees are key to our nation’s human spaceflight goals. I am continually impressed with what our workforce accomplishes and am proud to be named the leader of such an incredible team dedicated to mission excellence.”
      Koerner previously served as deputy director of NASA Johnson beginning in July 2021, overseeing strategic workforce planning, serving as Designated Agency Safety Health Officer (DASHO), and supporting the Johnson Center Director in mission reviews. Before his appointment to deputy director, Koerner served as director of the Flight Operations Directorate (FOD) for two years. In that role, he was responsible for selecting and protecting astronauts, and for the planning, training, and execution of human space flight and aviation missions. He managed an annual budget of $367 million, 600 civil servants and military personnel, and 2300 contractor personnel.  He oversaw the Astronaut Office, the Flight Director Office, the Mission Control Center, human spaceflight training facilities, and Johnson’s Aviation Operations Division. During this tenure he was also responsible for FOD’s flight readiness of the first commercial human spaceflight mission, ushering in a new era of domestic launch capability and the return of American astronauts launching from American soil. 
      Prior to assuming his position as director of Flight Operations, Koerner served in several senior executive roles, including:
      Johnson Space Center Associate Director from 2018 to 2019 Johnson Space Center Chief Financial Officer (CFO) from 2017 to 2018 Deputy Director of Flight Operations from 2014 to 2017 Deputy Director Mission Operations from 2007 to 2014 Koerner joined Johnson full-time in 1992. He has extensive operations experience including serving as an environmental systems space shuttle flight controller, where he supported 41 space shuttle flights in Mission Control. Since that time, he has served in a series of progressively more responsible positions, including lead for two International Space Station flight control groups, chief of the space station’s Data Systems Flight Control Branch, chief of the Mission Operations Directorate’s Management Integration Office, and as the Mission Operation Directorate’s manager for International Space Station operations.
      Additional special assignments throughout his career include:
      Project manager for Johnson’s Crew Exploration Vehicle Avionics Integration Lab (June 2007 –June 2008) Member of NASA’s Human Exploration Framework Team (April 2010 –October 2010) Member of NASA’s Standing Review Board that provided an independent assessment at life cycle review milestones for the Multi-Purpose Crew Vehicle Program, the Space Launch System Program and the Ground Systems Development and Operations Program (October 2011 – August 2014) Lead of NASA’s Mission Operations Capability Team (October 2015 –April 2017) “Steve has an accomplished career serving human spaceflight. His vision and dedication to the Johnson workforce makes him the perfect person to lead the Johnson team forward as acting director,” said Vanessa Wyche, NASA acting associate administrator. “Steve is an asset to the center and the agency—as both a proven technical expert and a leader.”
      Throughout his career, Koerner has been recognized for outstanding technical achievements and leadership, receiving two Superior Accomplishment Awards, the Outstanding Leadership Medal, the Johnson Space Center Director’s Commendation Award, two group achievement awards, the Exceptional Service Medal, and the Presidential Rank Award.
      Koerner is a native of Stow, Ohio. He earned a bachelor’s degree in mechanical engineering from the University of Akron in Ohio, and a master’s degree in business administration from LeTourneau University in Longview, Texas.
      View the full article
  • Check out these Videos

×
×
  • Create New...